Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interscalene blockade dosing regimens for shoulder surgery
2013-000235-27Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in shoulder fracture (2 arms), sponsored by University Hospital Odense. Primary endpoint: VAS score. Started Feb 2013; status: completed.
02
Drugs
ropivacaine
03
Conditions
shoulder fracture
Beyond the preview
Go deeper on 2013-000235-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000235-27.